Facial aesthetic unit remodeling procedure for neurofibromatosis type 1 hemifacial hypertrophy: Report on 33 consecutive adult patients

Plastic and Reconstructive Surgery

Volumn 125, Issue 4, 2010, Pages 1197-1207

  Hivelin, Mikaël ^a   Wolkenstein, Pierre ^b   Lepage, Christophe ^b   Valeyrie Allanore, Laurence ^b   Meningaud, Jean Paul ^b   Lantieri, Laurent ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; FACE TUMOR; FACTUAL DATABASE; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHY; LENGTH OF STAY; MALE; METHODOLOGY; MIDDLE AGED; NEUROFIBROMATOSIS; PATHOLOGY; PATIENT SATISFACTION; PLASTIC SURGERY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; RETROSPECTIVE STUDY; SKIN;

ADOLESCENT; ADULT; BLOOD TRANSFUSION; DATABASES, FACTUAL; FACIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY; LENGTH OF STAY; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; PATIENT SATISFACTION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SKIN; SURGERY, PLASTIC; YOUNG ADULT;

EID: 77951026074     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3181d180e9     Document Type: Article

References (80)

1. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet. 1989;26:704-711.
2. Huson SM, Compston DA, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales: II. Guidelines for genetic counselling. J Med Genet. 1989;26:712-721.
3. Peltonen J, Jaakkola S, Lebwohl M, et al. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest. 1988;59:760-771.
4. Huson S, Hughes R. The Neurofibromatoses: A Pathogenetic and Clinical Overview. 1st ed. New York: Chapman & Hall; 1994.
5. Harkin J, Reed R. Tumors of the Peripheral Nervous System. Washington, D.C.: Armed Forces Institute of Pathology; 1969.
6. Friedman JM, Riccardi VM. Clinical and epidemiologic features in NF1. In: Riccardi VM, ed. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Baltimore: Johns Hopkins University Press; 1992.
7. Friedman JM, Birch PH. Type 1 neurofibromatosis: A descriptive analysis of the disorder in 1,728 patients. Am J Med Genet. 1997;70:138-143.
8. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis: A clinical and population study in southeast Wales. Brain 1988;111:1355-1381.
9. Knight WA III, Murphy WK, Gottlieb JA. Neurofibromatosis associated with malignant neurofibromas. Arch Dermatol. 1973;107:747-750.
10. Maceri DR, Saxon KG. Neurofibromatosis of the head and neck. Head Neck Surg. 1984;6:842-850.
11. Verola O, Dallot A, Audebaud G, et al. Neurogenic sarcoma in Von Recklinghausen's disease: Histological, immunohistochemical and ultrastructural study of 6 cases (in French). Arch Anat Cytol Pathol. 1985;33:5-16.
12. Riccardi VM. Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr. 1992;22:66-106; discussion 107.
13. Zhu Y, Parada LF. The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002;2:616-626.
14. Szudek J, Joe H, Friedman JM. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1). Genet Epidemiol. 2002;23:150-164.
15. Duymaz A, Karabekmez FE, Keskin M, Tosun Z. Neurofibromatosis in a family: Is there a tendency to one side of the face? J Plast Reconstr Aesthet Surg. 2008;61:1169.
16. Le Wald L. Congenital absence of the superior orbital wall associated with pulsating exophthalmos: Report of four cases. AJR Am J Roentgenol. 1933:December;755-756.
17. Hunt JC, Pugh DG. Skeletal lesions in neurofibromatosis. Radiology 1961;76:1-20.
18. Binet EF, Kieffer SA, Martin SH, Peterson HO. Orbital dysplasia in neurofibromatosis. Radiology 1969;93:829-833.
19. Burrows EH. Bone changes in orbital neurofibromatosis. Br J Radiol. 1963;36:549-561.
20. Jackson IT, Laws ER Jr, Martin RD. The surgical management of orbital neurofibromatosis. Plast Reconstr Surg. 1983;71:751-758.
21. Jackson IT, Carbonnel A, Potparic Z, Shaw K. Orbitotemporal neurofibromatosis: Classification and treatment. Plast Reconstr Surg. 1993;92:1-11.
22. Munro IR, Martin RD. The management of gigantic benign craniofacial tumors: The reverse facial osteotomy. Plast Reconstr Surg. 1980;65:776-785.
23. Marchac D. Intracranial enlargement of the orbital cavity and palpebral remodeling for orbitopalpebral neurofibromatosis. Plast Reconstr Surg. 1984;73:534-543.
24. Marchac D, Britto JA. Remodelling the upper eyelid in the management of orbitopalpebral neurofibromatosis. Br J Plast Surg. 2005;58:944-956.
25. Harris WC Jr, Alpert WJ, Marcinko DE. Elephantiasis neuromatosa in von Recklinghausen's disease: A review and case report. J Am Podiatry Assoc. 1982;72:70-72.
26. Shack RB, Reilley AF, Lynch JB. Neurofibromas of the head and neck. South Med J. 1985;78:801-804.
27. Mimoun N, Razzouq N, Wolkenstein P, et al. Evaluation of skin viscoelasticity in type 1 neurofibromatosis patients. Skin Pharmacol Physiol. 2006;19:22-27.
28. Miyawaki T, Billings B, Har-Shai Y, et al. Multicenter study of wound healing in neurofibromatosis and neurofibroma. J Craniofac Surg. 2007;18:1008-1011.
29. Friedman JM, Gutmann D, Maccollin M, et al. Neurofibromatosis: Phenotype, Natural History, and Pathogenesis. Vol.1, 3rd ed. Baltimore: Johns Hopkins University Press; 1999.
30. Overdiek A, Feifel H, Schaper J, Mayatepek E, Rosenbaum T. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Brain Dev. 2006;28:275-280.
31. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol. 1988;45:575-578.
32. Wolkenstein P, Freche B, Zeller J, Revuz J. Usefulness of screening investigations in neurofibromatosis type 1: A study of 152 patients. Arch Dermatol. 1996;132:1333-1336.
33. Valeyrie-Allanore L, Ismaili N, Bastuji-Garin S, et al. Symptoms associated with malignancy of peripheral nerve sheath tumours: A retrospective study of 69 patients with neurofibromatosis 1. Br J Dermatol. 2005;153:79-82.
34. Gonzalez-Ulloa M. Restoration of the face covering by means of selected skin in regional aesthetic units. Br J Plast Surg. 1956;9:212-221.
35. Burget GC, Menick FJ. The subunit principle in nasal reconstruction. Plast Reconstr Surg. 1985;76:239-247.
36. Gonzalez-Ulloa M. Regional aesthetic units of the face. Plast Reconstr Surg. 1987;79:489-490.
37. Fattahi TT. An overview of facial aesthetic units. J Oral Maxillofac Surg. 2003;61:1207-1211.
38. Menick FJ. Facial reconstruction with local and distant tissue: The interface of aesthetic and reconstructive surgery. Plast Reconstr Surg. 1998;102:1424-1433.
39. Thomas J. Adjunctive tumescent technique in massive resections. Aesthetic Plast Surg. 2001;25:343-346.
40. Lindqvist C, Tveten S, Bondevik BE, Fagrell D. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg. 2005;115:282-289.
41. Lantieri L, Meningaud JP, Grimbert P, et al. Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: A 1-year follow-up study. Lancet 2008;372:639-645.
42. Van Der Meulen JC, Moscona AR, Vandrachen M, Hirshowitz B. The management of orbitofacial neurofibromatosis. Ann Plast Surg. 1982;8:213-220.
43. Ferrand JY, Staerman H, Watier E, Salahia S, Pailheret JP. Therapeutic attitude in extensive cutaneous lesions in Recklinghausen's disease (in French). Ann Chir Plast Esthet. 1991; 36:242-245.
44. Pailheret JP. Plastic surgery in benign cutaneous manifestations of von Recklinghausen's disease (in French). Chirurgie 1990;116:368-372.
45. Nahabedian MY, Rozen SM, Namnoum JD, Vander Kolk CA. Giant plexiform neurofibroma of the back. Ann Plast Surg. 2000;45:442-445.
46. Friedrich RE, Gehrke G, Giese M, Mautner VF, Schmelzle R. Tumor reduction of plexiform neurofibroma in the craniofacial and neck area (in German). Mund Kiefer Gesichtschir. 1998;2(Suppl 1):S86-S90.
47. Friedrich RE, Schmelzle R, Hartmann M, Mautner VF. Subtotal and total resection of superficial plexiform neurofibromas of face and neck: Four case reports. J Craniomaxillofac Surg. 2005;33:55-60.
48. Heuze Y, Piot B, Mercier J. Difficult surgical management of facial neurofibromatosis type I or von Recklinghausen disease in children (in French). Rev Stomatol Chir Maxillofac. 2002;103:105-113.
49. Van Der Meulen J. Orbital neurofibromatosis. Clin Plast Surg. 1987;14:123-135.
50. Davis WB, Edgerton MT, Hoffmeister SF. Neurofibromatosis of the head and neck. Plast Reconstr Surg (1946) 1954;14:186-199.
51. Griffith BH, McKinney P, Monroe CW, Howell A. Von Recklinghausen's disease in children. Plast Reconstr Surg. 1972;49:647-653.
52. Mukherji MM. Giant neurofibroma of the head and neck. Plast Reconstr Surg. 1974;53:184-189.
53. Grabb WC, Dingman RO, Oneal RM, Dempsey PD. Facial hamartomas in children: Neurofibroma, lymphangioma, and hemangioma. Plast Reconstr Surg. 1980;66:509-527.
54. Krueger W, Weisberger E, Ballantyne AJ, Goepfert A. Plexiform neurofibroma of the head and neck. Am J Surg. 1979; 138:517-520.
55. Ransom ER, Yoon C, Manolidis S. Single stage near total resection of massive pediatric head and neck plexiform neurofibromas. Int J Pediatr Otorhinolaryngol. 2006;70:1055-1061.
56. Nagata S. A systematic multiple stage surgical approach for attainment of satisfactory and favourable surgical results in an extremely severe von Recklinghausen's disease, elephantiasis neurofibromatosa. J Plast Reconstr Aesthet Surg. 2006;59: 662-674.
57. Chowdary RP, Little BW. Large vascular plexiform neurofibroma of scalp: Excision and coverage with free tissue transfer. Ann Plast Surg. 1990;24:75-79.
58. Weinrach JC, Cronin ED, Smith BK, CollinsDRJr, Cohen BE. Preventing seroma in the latissimus dorsi flap donor site with fibrin sealant. Ann Plast Surg. 2004;53:12-16.
59. Butler CE. Treatment of refractory donor-site seromas with percutaneous instillation of fibrin sealant. Plast Reconstr Surg. 2006;117:976-985.
60. Moore M, BurakWEJr, Nelson E, et al. Fibrin sealant reduces the duration and amount of fluid drainage after axillary dissection: A randomized prospective clinical trial. J Am Coll Surg. 2001;192:591-599.
61. Gilly FN, Francois Y, Sayag-Beaujard AC, Glehen O, Brachet A, Vignal J. Prevention of lymphorrhea by means of fibrin glue after axillary lymphadenectomy in breast cancer: Prospective randomized trial. Eur Surg Res. 1998;30:439-443.
62. Carless PA, Henry DA. Systematic review and meta-analysis of the use of fibrin sealant to prevent seroma formation after breast cancer surgery. Br J Surg. 2006;93:810-819.
63. Johnson L, Cusick TE, Helmer SD, Osland JS. Influence of fibrin glue on seroma formation after breast surgery. Am J Surg. 2005;189:319-323.
64. Kram HB, Clark SR, Ocampo HP, Yamaguchi MA, Shoemaker WC. Fibrin glue sealing of pancreatic injuries, resections, and anastomoses. Am J Surg. 1991;161:479-481; discussion 482.
65. Siedentop KH, O'Grady K, Park JJ, Bhattacharya T, Sanchez B. Fibrin sealant for treatment of cerebrospinal fluid leaks. Am J Otol. 1999;20:777-780.
66. Grossman JA, Capraro PA, Atagi T. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg. 2002;110:1371-1372.
67. Marchac D, Sandor G. Face lifts and sprayed fibrin glue: An outcome analysis of 200 patients. Br J Plast Surg. 1994;47: 306-309.
68. Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty BG. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg. 2001;108:2101- 2105; discussion 2106-2107.
69. Ochsner MG, Maniscalco-Theberge ME, Champion HR. Fibrin glue as a hemostatic agent in hepatic and splenic trauma. J Trauma 1990;30:884-887.
70. Kram HB, del Junco T, Clark SR, Ocampo HP, Shoemaker WC. Techniques of splenic preservation using fibrin glue. J Trauma 1990;30:97-101.
71. Canby-Hagino ED, Morey AF, Jatoi I, Perahia B, Bishoff JT. Fibrin sealant treatment of splenic injury during open and laparoscopic left radical nephrectomy. J Urol. 2000;164:2004-2005.
72. Modi P, Rahamim J. Fibrin sealant treatment of splenic injuries during oesophagectomy. Eur J Cardiothorac Surg. 2005; 28:167-168.
73. Olmi S, Scaini A, Erba L, Bertolini A, Guaglio M, Croce E. Use of fibrin glue (Tissucol) as a hemostatic in laparoscopic conservative treatment of spleen trauma. Surg Endosc. 2007; 21:2051-2054.
74. Czerny M, Verrel F, Weber H, et al. Collagen patch coated with fibrin glue components: Treatment of suture hole bleedings in vascular reconstruction. J Cardiovasc Surg (Torino) 2000;41:553-557.
75. Terashima M, Fujiwara S, Yaginuma GY, Takizawa K, Kaneko U, Meguro T. Outcome of percutaneous intrapericardial fibrin-glue injection therapy for left ventricular free wall rupture secondary to acute myocardial infarction. Am J Cardiol. 2008;101:419-421.
76. Littlewood AH, Stilwell JH. The vascular features of plexiform neurofibroma with some observations on the importance of pre-operative angiography and the value of preoperative intra-arterial embolisation. Br J Plast Surg. 1983; 36:501-506.
77. Mullan FJ, Herron BM, Curry RC. Fatal haemorrhage associated with neurofibromatosis. Eur J Vasc Surg. 1994;8:366-368.
78. Kuo LA, Kuo RS. Plexiform neurofibromatosis: A difficult surgical problem. Aust N Z J Surg. 1990;60:732-735.
79. Lantieri L, Wolkenstein P. Cutaneous manifestations of type 1 neurofibromatosis and their treatment (in French). Ann Chir Plast Esthet. 1998;43:445-454.
80. Needle MN, Cnaan A, Dattilo J, et al. Prognostic signs in the surgical management of plexiform neurofibroma: The Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr. 1997;131:678-682.